The Readout Loud show

The Readout Loud

Summary: Podcast by STAT

Join Now to Subscribe to this Podcast

Podcasts:

 Episode 71: Elon Musk's monkey cyborg, Gilead's shifting future, & an app for anxiety | File Type: audio/mpeg | Duration: 00:25:37

Can apps treat anxiety? Is Gilead Sciences back on track? And are we all just brains in a vat?

 Episode 70: A whirlwind week in Washington, Sean Parker's mansion, & remembering a voice in biotech | File Type: audio/mpeg | Duration: 00:29:52

Is drug pricing too complex for the Trump administration? Would you recognize Tom Hanks at a party? And what does it mean when famous executives quit?

 Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing | File Type: audio/mpeg | Duration: 00:25:31

Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?

 Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life | File Type: audio/mpeg | Duration: 00:26:49

Is desire a matter of medicine? Can you convict on genealogy? And what do you get the alleged bride who has it all?

 Episode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world | File Type: audio/mpeg | Duration: 00:25:03

Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out?

 Episode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party | File Type: audio/mpeg | Duration: 00:26:52

Who won ASCO? Is pharma sandbagging its blockbusters? And what do gladiators have to do with biotech?

 Episode 65: A special episode from the halls of the ASCO meeting | File Type: audio/mpeg | Duration: 00:29:25

What can be done to improve HPV vaccination rates in the U.S.? How does the genetic signature of a tumor lead to an effective cancer drug? What’s it like being a doctor and a cancer patient?

 Episode 64: Feuding professors, failing businesses, and journalism 101 | File Type: audio/mpeg | Duration: 00:24:00

Who's guilty of "clickbait"? Are spit tubes a bad business? And why are academics emulating Pusha T?

 Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer | File Type: audio/mpeg | Duration: 00:31:33

What should you watch for at the year's biggest cancer conference? Why are people having 23andMe-induced identity crises? And what's it like to be at once a journalist and a cancer patient?

 Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials | File Type: audio/mpeg | Duration: 00:23:24

Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?

 Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA | File Type: audio/mpeg | Duration: 00:25:04

Are law-breaking pharma executives the new mob bosses? Can genome editing preventing heart attacks? And can the FDA regulate drug prices?

 Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms | File Type: audio/mpeg | Duration: 00:22:21

Is Biogen bracing for a fight? What does Jack Daniels have to do with immunotherapy? And will "micro-dosing" light the way to actual therapies?

 Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup | File Type: audio/mpeg | Duration: 00:22:17

Who gets to be "influential"? Should you be skeptical of for-profit hospitals? And should George Lucas fire his attorneys?

 Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print | File Type: audio/mpeg | Duration: 00:21:34

Who gets to "play God"? Can old technologies learn new tricks? And what does "drug price" even mean?

 Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst | File Type: audio/mpeg | Duration: 00:25:22

How do you sell lefty ideas to righty politicians? What’s going on at Gilead Sciences? And why are biotech investors freaking out?

Comments

Login or signup comment.